319 related articles for article (PubMed ID: 29433518)
1. Optimization and scale up of microfluidic nanolipomer production method for preclinical and potential clinical trials.
Gdowski A; Johnson K; Shah S; Gryczynski I; Vishwanatha J; Ranjan A
J Nanobiotechnology; 2018 Feb; 16(1):12. PubMed ID: 29433518
[TBL] [Abstract][Full Text] [Related]
2. Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy.
Ranjan AP; Mukerjee A; Helson L; Vishwanatha JK
J Nanobiotechnology; 2012 Aug; 10():38. PubMed ID: 22937885
[TBL] [Abstract][Full Text] [Related]
3. Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells.
Li L; Xiang D; Shigdar S; Yang W; Li Q; Lin J; Liu K; Duan W
Int J Nanomedicine; 2014; 9():1083-96. PubMed ID: 24591829
[TBL] [Abstract][Full Text] [Related]
4. Microfluidic fabrication and characterization of Sorafenib-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery.
Tahir N; Madni A; Li W; Correia A; Khan MM; Rahim MA; Santos HA
Int J Pharm; 2020 May; 581():119275. PubMed ID: 32229283
[TBL] [Abstract][Full Text] [Related]
5. Development and characterization of gemcitabine hydrochloride loaded lipid polymer hybrid nanoparticles (LPHNs) using central composite design.
Yalcin TE; Ilbasmis-Tamer S; Takka S
Int J Pharm; 2018 Sep; 548(1):255-262. PubMed ID: 29969712
[TBL] [Abstract][Full Text] [Related]
6. Passively Targeted Curcumin-Loaded PEGylated PLGA Nanocapsules for Colon Cancer Therapy In Vivo.
Klippstein R; Wang JT; El-Gogary RI; Bai J; Mustafa F; Rubio N; Bansal S; Al-Jamal WT; Al-Jamal KT
Small; 2015 Sep; 11(36):4704-22. PubMed ID: 26140363
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
[TBL] [Abstract][Full Text] [Related]
8. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy.
Mukerjee A; Vishwanatha JK
Anticancer Res; 2009 Oct; 29(10):3867-75. PubMed ID: 19846921
[TBL] [Abstract][Full Text] [Related]
9. Microfluidic Manufacturing of Multitargeted PLGA/PEG Nanoparticles for Delivery of Taxane Chemotherapeutics.
Martins C; Sarmento B
Methods Mol Biol; 2020; 2059():213-224. PubMed ID: 31435924
[TBL] [Abstract][Full Text] [Related]
10. Development of bicalutamide-loaded PLGA nanoparticles: preparation, characterization and in-vitro evaluation for the treatment of prostate cancer.
Ray S; Ghosh Ray S; Mandal S
Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):944-954. PubMed ID: 27327352
[TBL] [Abstract][Full Text] [Related]
11. The remarkable role of emulsifier and chitosan, dextran and PEG as capping agents in the enhanced delivery of curcumin by nanoparticles in breast cancer cells.
Sampath M; Pichaimani A; Kumpati P; Sengottuvelan B
Int J Biol Macromol; 2020 Nov; 162():748-761. PubMed ID: 32585267
[TBL] [Abstract][Full Text] [Related]
12. Amphotericin B-loaded polymeric nanoparticles: formulation optimization by factorial design.
Carraro TC; Khalil NM; Mainardes RM
Pharm Dev Technol; 2016 Mar; 21(2):140-6. PubMed ID: 25384838
[TBL] [Abstract][Full Text] [Related]
13. Preparation, characterization and uptake of PEG-coated, muco-inert nanoparticles in HGC-27 cells, a mucin-producing, gastric-cancer cell line.
Lin D; Li G; Qin L; Wen Z; Wang J; Sun X
J Biomed Nanotechnol; 2013 Dec; 9(12):2017-23. PubMed ID: 24266257
[TBL] [Abstract][Full Text] [Related]
14. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery.
Parveen S; Sahoo SK
Eur J Pharmacol; 2011 Nov; 670(2-3):372-83. PubMed ID: 21951969
[TBL] [Abstract][Full Text] [Related]
15. The Use of an Efficient Microfluidic Mixing System for Generating Stabilized Polymeric Nanoparticles for Controlled Drug Release.
Morikawa Y; Tagami T; Hoshikawa A; Ozeki T
Biol Pharm Bull; 2018; 41(6):899-907. PubMed ID: 29863078
[TBL] [Abstract][Full Text] [Related]
16. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells.
Yallapu MM; Gupta BK; Jaggi M; Chauhan SC
J Colloid Interface Sci; 2010 Nov; 351(1):19-29. PubMed ID: 20627257
[TBL] [Abstract][Full Text] [Related]
17. Design of PLGA nanoparticles for sustained release of hydroxyl-FK866 by microfluidics.
Bai X; Tang S; Butterworth S; Tirella A
Biomater Adv; 2023 Nov; 154():213649. PubMed ID: 37820459
[TBL] [Abstract][Full Text] [Related]
18. Multivariate analysis for the optimization of microfluidics-assisted nanoprecipitation method intended for the loading of small hydrophilic drugs into PLGA nanoparticles.
Chiesa E; Dorati R; Modena T; Conti B; Genta I
Int J Pharm; 2018 Jan; 536(1):165-177. PubMed ID: 29175645
[TBL] [Abstract][Full Text] [Related]
19. A robust systematic design: Optimization and preparation of polymeric nanoparticles of PLGA for docetaxel intravenous delivery.
Rafiei P; Haddadi A
Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109950. PubMed ID: 31499976
[TBL] [Abstract][Full Text] [Related]
20. Polyethylene glycol triggers the anti-cancer impact of curcumin nanoparticles in sw-1736 thyroid cancer cells.
Hosseinzadeh S; Nazari H; Esmaeili E; Hatamie S
J Mater Sci Mater Med; 2021 Aug; 32(9):112. PubMed ID: 34453618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
